Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center

BACKGROUND: Left Ventricular Assist Device (LVAD) is a promising therapy for patients with advanced heart failure (HF), but bleeding complications remain an important issue. Previous series show that acquired von Willebrand syndrome was present in up to 100 % of first generation LVAD recipients. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmaeilzadeh, Fatemeh, Wauters, Aurélien, Wijns, Walter, Argacha, Jean-François, van de Borne, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969666/
https://www.ncbi.nlm.nih.gov/pubmed/27485105
http://dx.doi.org/10.1186/s12872-016-0334-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969666/
https://www.ncbi.nlm.nih.gov/pubmed/27485105
http://dx.doi.org/10.1186/s12872-016-0334-z

Ejemplares similares